Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome

Immune response to therapeutic enzymes poses a detriment to patient safety and treatment outcome. Enzyme replacement therapy (ERT) is a standard therapeutic option for some types of mucopolysaccharidoses, including Morquio A syndrome caused by N-acetylgalactosamine-6-sulfate sulfatase (GALNS) defici...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Invest
Egile Nagusiak: Sosa, Angela C., Kariuki, Barbara, Gan, Qi, Knutsen, Alan P., Bellone, Clifford J., Guzmán, Miguel A., Barrera, Luis A., Tomatsu, Shunji, Chauhan, Anil K., Armbrecht, Eric, Montaño, Adriana M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269574/
https://ncbi.nlm.nih.gov/pubmed/31743109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI125607
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak